β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp.
Food & Function · 2024
DOI: 10.1039/d4fo02416h ↗Kurz gefasst
Fachartikel in der Zeitschrift Food & Function, 2024. Verfasst von Damien Paul Belobrajdic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Commonwealth Scientific Industrial Research Organisation (CSIRO) Health and Biosecurity, Adelaide, South Australia, Australia. damien.belobrajdic@csi…. Hauptthemen laut MEDLINE: Agaricus, Pleurotus, beta-Glucans, Bile Acids and Salts. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Hort Innovation.
Abstract (Originalsprache)
The cholesterol lowering properties of oats and barley, attributed to their high β-glucan content, are well established, but it remains unclear whether mushrooms, also rich in β-glucan, exhibit a similar functionality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Commonwealth Scientific Industrial Research Organisation (CSIRO) Health and Biosecurity, Adelaide, South Australia, Australia. damien.belobrajdic@csiro.au.
- College of Medicine and Public Health, Health Flinders University, Bedford Park, SA 5042, Australia.
Förderung
- Hort Innovation
Zitieren
APA
Belobrajdic, D. P., Brook, H., James-Martin, G., & Stonehouse, W. (2024). β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp. Food & Function. https://doi.org/10.1039/d4fo02416h
Vancouver
Belobrajdic DP, Brook H, James-Martin G, Stonehouse W. β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp. Food & Function. 2024. doi:10.1039/d4fo02416h
BibTeX
@article{Belobrajdic2024,
author = {Belobrajdic, Damien Paul and Brook, Henri and James-Martin, Genevieve and Stonehouse, Welma},
title = {β-Glucan content and in vitro bile-acid binding capacity of Agaricus bisporus and Pleurotus spp},
journal = {Food & Function},
year = {2024},
doi = {10.1039/d4fo02416h}
}
EUVIMED